Table 3. Participants in study comparing Leishmania typing results in 16 European clinical laboratories, 2014.
Institute | City | Country |
---|---|---|
Institute of Tropical Medicine Antwerpa | Antwerp | Belgium |
Centre National de Référence des Leishmaniosesa,b | Montpellier | France |
Centre Hospitalier Universitaire de Rennes | Rennes | France |
Charité-Universitätsmedizin Berlin | Berlin | Germany |
Hebrew University-Hadassah Medical Centre | Jerusalem | Israel |
Istituto Superiore di Sanità | Rome | Italy |
National Institute for Infectious Diseases L. Spallanzani | Rome | Italy |
Instituto de Higiene e Medicina Tropical | Lisbon | Portugal |
Instituto de Salud Carlos III | Majadahonda | Spain |
The Public Health Agency of Sweden | Stockholm | Sweden |
Swiss Tropical and Public Health Institutea | Basel | Switzerland |
Institute of Parasitology | Zürich | Switzerland |
Academic Medical Center, University of Amsterdam | Amsterdam | The Netherlands |
National Institute for Public Health and the Environment | Bilthoven | The Netherlands |
St. Elisabeth Hospital | Tilburg | The Netherlands |
Ege University Medical School | Izmir | Turkey |
Hospital for Tropical Diseases | London | United Kingdom |
Institutes are listed in alphabetical order based on country and city.
a These laboratories provided parasite cultures and DNA.
b This laboratory applied one of the reference methods (MLSA) and did not participate in the comparative study of typing outcomes.